Mark A. Ritter

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer”.

A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer

Practical Radiation Oncology(2020)10.1016/j.prro.2020.02.013

N/A

0DataRank · unranked

4 citations

Patrick A. Kupelian, Daniel G. Petereit, C.A. Lawton, Nick Anger, Heather M. Geye +3 more

Toxicity and Patient-Reported Quality-of-Life Outcomes After Prostate Stereotactic Body Radiation Therapy With Focal Boost to Magnetic Resonance Imaging-Identified Prostate Cancer Lesions: Results of a Phase 2 Trial

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.05.004

N/A

0DataRank · unranked

13 citations

Emma E. Holmes, N. Anger, Gregory Cooley, Jéssica Schuster, Newton J. Hurst +9 more

Using 18F-DCFPyL Prostate-Specific Membrane Antigen–Directed Positron Emission Tomography/Magnetic Resonance Imaging to Define Intraprostatic Boosts for Prostate Stereotactic Body Radiation Therapy

Advances in Radiation Oncology(2023)10.1016/j.adro.2023.101241

N/A

0DataRank · unranked

4 citations

Shane A. Wells, Diane Ojala, R. A. Bayliss, Patrick M. Hill, Brett Morris +4 more